114 related articles for article (PubMed ID: 30375933)
1. Can Susceptibility-weighted MRI Help Differentiate Osteolytic from Osteoblastic Spine Metastases?
Schweitzer ME
Radiology; 2019 Jan; 290(1):155-156. PubMed ID: 30375933
[No Abstract] [Full Text] [Related]
2. Differentiation of Predominantly Osteoblastic and Osteolytic Spine Metastases by Using Susceptibility-weighted MRI.
Böker SM; Adams LC; Bender YY; Fahlenkamp UL; Wagner M; Hamm B; Makowski MR
Radiology; 2019 Jan; 290(1):146-154. PubMed ID: 30375926
[TBL] [Abstract][Full Text] [Related]
3. [Imaging of osteosclerotic metastases].
Feydy A; Carlier R; Vallée C; Mompoint D; Chevallier A; Engerand S; Bhavsar P; Ollivier L
J Radiol; 1995 Sep; 76(9):561-72. PubMed ID: 7473396
[TBL] [Abstract][Full Text] [Related]
4. Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum?
Ortiz A; Lin SH
Recent Results Cancer Res; 2012; 192():225-33. PubMed ID: 22307378
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
[TBL] [Abstract][Full Text] [Related]
7. 11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
Ceci F; Castellucci P; Graziani T; Schiavina R; Chondrogiannis S; Bonfiglioli R; Costa S; Virgolini IJ; Rubello D; Fanti S; Colletti PM
Clin Nucl Med; 2015 May; 40(5):e265-70. PubMed ID: 25783519
[TBL] [Abstract][Full Text] [Related]
8. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
9. [
Janssen JC; Woythal N; Meißner S; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
Mol Imaging Biol; 2017 Dec; 19(6):933-943. PubMed ID: 28707038
[TBL] [Abstract][Full Text] [Related]
10. Multimodal μCT/μMR based semiautomated segmentation of rat vertebrae affected by mixed osteolytic/osteoblastic metastases.
Hojjat SP; Foltz W; Wise-Milestone L; Whyne CM
Med Phys; 2012 May; 39(5):2848-53. PubMed ID: 22559657
[TBL] [Abstract][Full Text] [Related]
11. PET Tracer
Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
Theranostics; 2017; 7(7):2048-2064. PubMed ID: 28656060
[No Abstract] [Full Text] [Related]
12. [Clinical imaging of osteo-condensed metastases].
Buthiau D; Antoine EC; Lapresle P; Wechsler B; Missenard G; Misset JL; Denarnaud J; Khayat D; Ziza JM
Rev Med Interne; 1999 Apr; 20(4):353-64. PubMed ID: 10327481
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology.
Merz M; Seyler L; Bretschi M; Semmler W; Bäuerle T
Eur J Radiol; 2015 Apr; 84(4):623-30. PubMed ID: 25641009
[TBL] [Abstract][Full Text] [Related]
14. Role of Wnts in prostate cancer bone metastases.
Hall CL; Kang S; MacDougald OA; Keller ET
J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
[TBL] [Abstract][Full Text] [Related]
15. Intertrabecular pattern of tumors metastatic to bone.
Yamaguchi T; Tamai K; Yamato M; Honma K; Ueda Y; Saotome K
Cancer; 1996 Oct; 78(7):1388-94. PubMed ID: 8839543
[TBL] [Abstract][Full Text] [Related]
16. Anatomic and functional imaging in the diagnosis of spine metastases and response assessment after spine radiosurgery.
Soliman M; Taunk NK; Simons RE; Osborne JR; Kim MM; Szerlip NJ; Spratt DE
Neurosurg Focus; 2017 Jan; 42(1):E5. PubMed ID: 28041315
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of hemangiomas from spinal osteolytic metastases using 3.0 T MRI: comparison of T1-weighted imaging, chemical-shift imaging, diffusion-weighted and contrast-enhanced imaging.
Shi YJ; Li XT; Zhang XY; Liu YL; Tang L; Sun YS
Oncotarget; 2017 Sep; 8(41):71095-71104. PubMed ID: 29050345
[TBL] [Abstract][Full Text] [Related]
19. Sclerotic bone metastases from sarcomatoid renal cell carcinoma.
Liu PT; Conley CR; Callstrom MR
Skeletal Radiol; 1999 Oct; 28(10):590-3. PubMed ID: 10550538
[TBL] [Abstract][Full Text] [Related]
20. [The radiodiagnosis of bone metastases from melanoma].
Potepan P; Spagnoli I; Danesini GM; Laffranchi A; Gadda D; Mascheroni L; Guzzon A
Radiol Med; 1994 Jun; 87(6):741-6. PubMed ID: 8041925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
